0001366340-17-000100.txt : 20171214 0001366340-17-000100.hdr.sgml : 20171214 20171214171927 ACCESSION NUMBER: 0001366340-17-000100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171212 FILED AS OF DATE: 20171214 DATE AS OF CHANGE: 20171214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Noonan Michael David CENTRAL INDEX KEY: 0001332664 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33304 FILM NUMBER: 171256964 MAIL ADDRESS: STREET 1: 2000 UNIVERSITY AVE, SUITE 600 CITY: PALO ALTO STATE: CA ZIP: 94303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FINJAN HOLDINGS, INC. CENTRAL INDEX KEY: 0001366340 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 204075963 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 UNIVERSITY AVENUE STREET 2: SUITE 600 CITY: EAST PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: (650) 282-3228 MAIL ADDRESS: STREET 1: 2000 UNIVERSITY AVENUE STREET 2: SUITE 600 CITY: EAST PALO ALTO STATE: CA ZIP: 94303 FORMER COMPANY: FORMER CONFORMED NAME: Converted Organics Inc. DATE OF NAME CHANGE: 20060616 4 1 wf-form4_151328995372229.xml FORM 4 X0306 4 2017-12-12 0 0001366340 FINJAN HOLDINGS, INC. FNJN 0001332664 Noonan Michael David C/O FINJAN HOLDINGS, INC. 2000 UNIVERSITY AVE, SUITE 600 E. PALO ALTO CA 94303 0 1 0 0 Chief Financial Officer Common Stock Option (right to buy) 2.25 2017-12-12 4 A 0 50000 0 A 2018-12-12 2027-12-12 Common Stock 50000.0 50000 D Common Stock Option (right to buy) 2.25 2017-12-12 4 A 0 70000 0 A 2019-12-12 2027-12-12 Common Stock 70000.0 70000 D Common Stock Option (right to buy) 2.25 2017-12-12 4 A 0 70000 0 A 2020-12-12 2027-12-12 Common Stock 70000.0 70000 D The option will vest and become exercisable as to 3,333 shares of common stock of Finjan Holdings, Inc. on the first anniversary of the grant date and vest as to 12.5% of the remaining balance of the shares of common stock in equal installments every three calendar months thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on December 12, 2020. The option will vest and become exercisable as to 33.3333% of the original grant on the second anniversary of the grant date and vest as to 8.3333% of the original grant in equal installments every three calendar months thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on December 12, 2021. The option will vest and become exercisable as to 33.3333% of the original grant on the third anniversary of the grant date and vest as to 8.3333% of the original grant in equal installments every three calendar months thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on December 12, 2022. /s/ Michael Noonan 2017-12-14